Literature DB >> 9611006

Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway.

T Iversen1, S Tretli.   

Abstract

OBJECTIVE: To characterize time trends in incidence of intraepithelial and invasive vulvar neoplasia, transition of intraepithelial vulvar neoplasia to invasive cancer, and survival rate based on a total population.
METHODS: The Cancer Registry of Norway was used to identify all Norwegian inhabitants diagnosed during 1956-1990 with squamous cell carcinoma of the vulva, and all those with intraepithelial vulvar neoplasia diagnosed during 1973-92.
RESULTS: The incidence rate of intraepithelial neoplasia increased three-fold from 1973-77 to 1988-92, and 3.4% changed into invasive disease. Multivariate analyses identified age as a significant variable. The age-adjusted incidence rate for squamous cell carcinoma was constant for the whole period. The ratio between recurrence and the total number of invasive cancer varied from 21% to 31%. The 5-year survival rates have not changed significantly over the period. Age was revealed as a strong prognostic factor, showing an excess death rate by increasing age.
CONCLUSION: The incidence of vulvar intraepithelial neoplasia has increased substantially over the last 40 years, but that of invasive vulvar cancer has not changed appreciably.

Entities:  

Mesh:

Year:  1998        PMID: 9611006     DOI: 10.1016/s0029-7844(98)00101-x

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

1.  Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.

Authors:  Krystle A Lang Kuhs; Paula Gonzalez; Ana Cecilia Rodriguez; Leen-Jan van Doorn; Mark Schiffman; Linda Struijk; Sabrina Chen; Wim Quint; Douglas R Lowy; Carolina Porras; Corey DelVecchio; Silvia Jimenez; Mahboobeh Safaeian; John T Schiller; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Aimée R Kreimer
Journal:  J Infect Dis       Date:  2014-06-23       Impact factor: 5.226

2.  Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.

Authors:  Monika Hampl; Nicolas Wentzensen; Svetlana Vinokurova; Magnus von Knebel-Doeberitz; Cristopher Poremba; Hans G Bender; Volkmar Kueppers
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-25       Impact factor: 4.553

3.  Use of the Sentinel Lymph Node Technique Compared to Complete Inguino-femoral Lymph Node Removal in Patients with Invasive Vulvar Cancer in Germany.

Authors:  F Kramer; H Hertel; P Hillemanns
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-02       Impact factor: 2.915

4.  Vulvar Intraepithelial Neoplasia 3 in Women Less Than 35 Years.

Authors:  Joshua P Kesterson; Shashikant Lele
Journal:  J Low Genit Tract Dis       Date:  2009-10       Impact factor: 1.925

Review 5.  [Impact of prophylactic HPV vaccines on dermatology and venereology].

Authors:  G Gross
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

Review 6.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

7.  Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway.

Authors:  Espen Enerly; Freddie Bray; Christine Mellem; Bo Terning Hansen; Grete Kjølberg; Tove Dahl; Tom Børge Johannesen; Mari Nygård
Journal:  Acta Oncol       Date:  2011-11-02       Impact factor: 4.089

8.  Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis.

Authors:  Zhihui Wang; Ana Slipicevic; Mette Førsund; Claes G Trope; Jahn M Nesland; Ruth Holm
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

9.  Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.

Authors:  Alice R Rumbold; Sarah E Tan; John R Condon; Debbie Taylor-Thomson; Maria Nickels; Sepehr N Tabrizi; Margaret L J Davy; Margaret M O'Brien; Christine M Connors; Ibrahim Zardawi; Jim Stankovich; Suzanne M Garland
Journal:  BMC Infect Dis       Date:  2012-10-05       Impact factor: 3.090

10.  Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.

Authors:  H P van de Nieuwenhof; L F A G Massuger; J A de Hullu; M A P C van Ham; J A A M van Dijck; A G Siebers; R L M Bekkers
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.